FDA Approved: TIMOPTIC IN OCUDOSE — Original Application (Nordic Pharma, Inc.)

View source ↗

Summary

FDA approves Nordic Pharma's TIMOPTIC IN OCUDOSE (timolol maleate) under an original ANDA application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TIMOPTIC IN OCUDOSE (Timolol maleate)

Snippet

ORIG AP for TIMOPTIC IN OCUDOSE (TIMOLOL MALEATE)